ARIKAYCE 590 mg/8.4mL
Amikacin · SUSPENSION · Insmed Incorporated
No Recall History
Plain English
ARIKAYCE is a suspension containing amikacin at 590 mg/8.4mL, taken respiratory (inhalation). Manufactured by Insmed Incorporated.
Key Facts
- Brand Name
- ARIKAYCE
- Generic Name
- Amikacin
- NDC Code (Product)
71558-590- Manufacturer
- Insmed Incorporated
- Strength
- 590 mg/8.4mL
- Dosage Form
- SUSPENSION
- Route
- RESPIRATORY (INHALATION)
- Marketing Status
- Application #
- NDA207356
- Drug Class
- Aminoglycoside Antibacterial [EPC]
- Marketing Start
- 10/12/2018
Recall History
No Recall HistoryFrequently Asked Questions
What is ARIKAYCE used for?
ARIKAYCE contains Amikacin. It is a suspension taken respiratory (inhalation). Consult your doctor for specific uses.
Is ARIKAYCE a controlled substance?
ARIKAYCE is not classified as a controlled substance by the DEA.
What is the generic name for ARIKAYCE?
The generic name for ARIKAYCE is Amikacin. There are 11 other brand versions of Amikacin.
What is the NDC code for ARIKAYCE 590 mg/8.4mL?
The NDC (National Drug Code) for ARIKAYCE 590 mg/8.4mL is 71558-590, listed by Insmed Incorporated.
Other Amikacin Brands
See all →- Amikacin Sulfate500 mg/2mL23155-785
- Amikacin Sulfate1 g/4mL23155-786
- amikacin sulfate250 mg/mL25021-173
- Amikacin Sulfate250 mg/mL0641-6167
- Amikacin Sulfate250 mg/mL0641-6166
- Amikacin Sulfate250 mg/mL23155-290
- Amikacin Sulfate250 mg/mL67184-0569
- Amikacin Sulfate250 mg/mL83301-0022
- Amikacin Sulfate250 mg/mL83301-0023
- Amikacin Sulfate250 mg/mL63323-815
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)